Collecting patient experiences in radiation oncology
Official title: Patient Experience Data in Radiation Oncology
Run by Medical University of Vienna · NCT05224297 · Data updated 2026-11-12
This study is trying to create a tool that collects feedback from cancer patients about the side effects they experience during and after radiation treatment to improve their care.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years to 100 Years |
| Sex | All |
| Enrollment | 6000 (estimated) |
| Sponsor | Medical University of Vienna Academic / other |
| Drugs / interventions | radiation |
| Locations | 1 site (Vienna, State of Vienna) |
| Status | Recruiting |
| Started | October 1, 2020 |
| Main results expected | January 1, 2025 |
| Study ends | January 1, 2025 |
| Registry record updated | November 22, 2024 |
| Trial ID | NCT05224297 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are all patients receiving external beam radiotherapy.
✕Probably not a fit
Patients who are unable to independently answer questionnaires about radiation-induced side effects will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This project aims to enhance patient-centered care in radiation oncology by developing a tool to gather patient-reported outcome data regarding side effects experienced during and after radiotherapy. It will create a real-world evidence database to monitor and evaluate advancements in treatment technologies and protocols. The collected data will be pseudonymized and linked to existing oncological and dosimetric information systems, forming a foundation for future patient-oriented clinical developments.
Why it matters
Potential benefit: If successful, this initiative could lead to improved management of side effects in patients undergoing radiotherapy.
How similar studies have gone: While this approach is focused on patient-reported outcomes, similar studies have shown success in enhancing patient care through real-world evidence collection.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * all patients receiving external beam radiotherapy Exclusion Criteria: * unable to independently answer questionnaires on radiation-induced side effects
Where it's running
-
Medical University of Vienna
Vienna, State of Vienna, Austria Recruiting
Study contacts
- Study coordinator: Gerd Heilemann, PhD
- Email: gerd.heilemann@meduniwien.ac.at
- Phone: 004314040072710
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Affordable, tailored physical therapy for financially vulnerable people after trauma
We’re testing whether a patient-friendly, low-cost approach to physical therapy helps adults with trauma injuries who are financially vulnerable maintain or improve their quality of life.
-
A child-friendly way for kids to report their experiences around anesthesia and surgery
This project will test a Danish translation of a child-friendly recovery and experience questionnaire (PedSQoR) with 4–12-year-old surgical patients to let children report their own perioperative outcomes and experiences.
-
Self‑manual lymph drainage for head and neck lymphedema
This trial will test whether different intensities of self‑applied manual lymph drainage help people with head and neck lymphedema after radiotherapy for oropharyngeal cancer.
-
Health-Oriented Protocol for Epidermal Radiodermatitis
This study looks at how skin reactions from radiation therapy affect adults with head/neck or pelvic cancers and whether certain factors influence RID outcomes.
-
Using patient-reported questionnaires to monitor quality of life during first-line chemo-immunotherapy for advanced NSCLC
This project will test whether regular online questionnaires about symptoms and quality of life can help track health and treatment effects in adults with stage IV NSCLC starting first-line chemo-immunotherapy.
-
Skipping the clinical target volume (CTV) around the primary tumor in limited-stage small cell lung cancer
This trial tests whether giving chest radiotherapy that skips the usual extra margin around the main tumor is as effective and causes fewer side effects for people with limited-stage small cell lung cancer who have responded to initial chemotherapy.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.